Hologic Q3 EPS $0.93 Beats $0.88 Estimate, Sales $984.40M Beat $957.13 Estimate
Portfolio Pulse from Benzinga Newsdesk
Hologic (NASDAQ:HOLX) reported Q3 earnings of $0.93 per share, beating the analyst consensus estimate of $0.88 by 5.68%. However, this is a 2.11% decrease from the same period last year. The company also reported quarterly sales of $984.40 million, surpassing the analyst consensus estimate of $957.13 million by 102.85M%, but this is a 1.85% decrease from the same period last year.
July 31, 2023 | 8:18 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Hologic's Q3 earnings and sales exceeded analyst estimates, but both are slightly down from the same period last year.
While Hologic beat analyst estimates for Q3 earnings and sales, the slight decrease from the same period last year might cause some investor concern. This mixed result could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100